Fc. Dwamena et al., The use of angiotensin-converting enzyme inhibitors in patients with acutemyocardial infarction in community hospitals, CLIN CARD, 23(5), 2000, pp. 341-346
Background: Previous studies documenting underutilization of angiotensin-co
nverting enzyme inhibitors (ACEIs) in acute myocardial infarction (AMI) hav
e been limited to Medicare populations.
Hypothesis: This study examines ACEI prescription rates and predictors in a
community sample of hospitalized patients with AMI.
Methods;: The charts of 1163 community patients with AMI, prospectively ide
ntified at admission between January 1, 1994, and April 30, 1995, were revi
ewed.
Results: Only 64 of 158 (40%) patients considered ideal candidates for ACEI
prescription were discharged with a prescription for an ACEI. In a multiva
riate logistic regression model, prior ACEI utilization [adjusted odds rati
on (OR) = 3.26; 95% confidence interval (CI)= 2.05-5.20], presence of conge
stive heart failure (OR = 2.33; CI = 1.50-3.61) and blackrace (OR = 2.20; C
I = 1.34-3.64) were identified as positive predictors of ACEI prescription.
Conversely, lack of left ventricular ejection fraction (LVEF) measurement
(OR = 0.46; CI = 0.28-0.75), LVEF > 40 ( OR = 0.27; CI = 0.18-0.40), and ac
ute renal failure ( OR = 0.08; CI = 0.01-0.44) were negative predictors. Wo
men were also less Likely to be discharged with an ACEI prescription (OR =
0.71; CI = 0.48-1.05). Furthermore, women were significantly less likely to
have LVEF measured prior to discharge than were males (77 vs. 85%, p = 0.0
01).
Conclusion: This study underscores the need for improvement in the utilizat
ion of ACEI in eligible patients with AMI. It also identifies opportunities
for improvement in prescription rates, especially in women.